CryoLife to Present at Banc of America Securities Health Care Conference In Las Vegas
A live webcast of the conference will be available at http://www.veracast.com/webcasts/bas/healthcare-2003/id81307102.cfm . The audio portion of CryoLife's presentation may also be accessed at www.cryolife.com on the investor relations page. An archived copy of the presentation will be available through Friday, April 11 at 5:00 p.m. Pacific Daylight Time on both Web sites.
Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiovascular and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) surgical adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels and is CE marked in the European Community and approved in Canada for use in soft tissue repair and approved in Australia for use in vascular and pulmonary sealing and repair. The Company also manufactures the SynerGraft vascular graft, which is CE marked for distribution within the European Community.
For additional information about the company, visit CryoLife's web site: http://www.cryolife.com .
Media Contacts:
D. Ashley Lee
Vice President & Chief Financial Officer and Treasurer
Phone: 770-419-3355
Katie Brazel
Fleishman Hillard
Phone: 404-739-0150
SOURCE CryoLife, Inc.
CONTACT: D. Ashley Lee, Vice President & Chief Financial Officer and
Treasurer of CryoLife, Inc., +1-770-419-3355, or Katie Brazel of Fleishman
Hillard, +1-404-739-0150, for CryoLife, Inc.
URL: http://www.cryolife.com
